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Summary
InmtDNAmutatormice,mtDNAmutations accumulate leading to a
rapidly aging phenotype. However, there is little evidence of
oxidative damage to tissues, and when analyzed ex vivo, no
change in production of the reactive oxygen species (ROS) super-
oxide and hydrogen peroxide bymitochondria has been reported,
undermining themitochondrial oxidative damage theory of aging.
Paradoxically, interventions that decrease mitochondrial ROS
levels in vivo delay onset of aging. To reconcile these findings,
we used the mitochondria-targeted mass spectrometry probe
MitoB to measure hydrogen peroxide within mitochondria of
living mice. Mitochondrial hydrogen peroxide was the same in
young mutator and control mice, but as the mutator mice aged,
hydrogen peroxide increased. This suggests that the prolonged
presenceofmtDNAmutations in vivo increases hydrogenperoxide
that contributes to an accelerated aging phenotype, perhaps
through the activation of pro-apoptotic and pro-inflammatory
redox signaling pathways.
Key words: hydrogen peroxide; MitoB; mitochondria; mito-
chondrial DNA; mtDNA mutator mice.
In mtDNA mutator mice (Trifunovic et al., 2004; Kujoth et al., 2005), the
proof-reading domain of mitochondrial DNA polymerase c is disrupted
by a point mutation (D257A) and ‘knocked in’ to all tissues (Trifunovic
et al., 2004; Kujoth et al., 2005). This leads to the accumulation of
mtDNA mutations with age, giving rise to defective mitochondria and an
accelerated aging phenotype that is evident from ~5 months (Trifunovic
et al., 2004; Kujoth et al., 2005; Edgar et al., 2009; Hiona et al., 2010).
The mitochondrial free radical theory of aging suggested that superoxide
production by the respiratory chain leads to mtDNA damage, resulting
in the assembly of defective respiratory chains that produce more
superoxide, establishing a vicious cycle that underlies aging (Harman,
1972). However, most studies have reported negligible increases in
oxidative damage in mutator mice (with one exception of a modest,
~19%, increase in protein carbonyls (Dai et al., 2010)), or expression of
antioxidant enzymes, and the levels of ROS produced by mutator
mitochondria or embryonic fibroblasts have been reported to be the
same as controls when analyzed ex vivo, despite the accumulation of
mtDNA mutations (Kujoth et al., 2005; Trifunovic et al., 2005; Hiona
et al., 2010). These findings suggested that a vicious cycle of disruptive
mitochondrial oxidative damage does not underlie normal aging (Loeb
et al., 2005; Vermulst et al., 2007).
Recently, however, studies have shown that elevated mitochondrial
ROS may yet contribute to aging in mutator mice. Expression of catalase
within mitochondria (Dai et al., 2010), treatment with N-acetyl cysteine
(Ahlqvist et al., 2012), or endurance exercise (Safdar et al., 2011) all
delayed the onset of aging. All these interventions can decrease
mitochondrial superoxide (Murphy, 2009; Cocheme et al., 2011), sug-
gesting that mitochondrial ROS may contribute to the aging of mutator
mice in vivo, but without changing ex vivomitochondrial ROS or markedly
increasing oxidative damage.
An insight that may reconcile these apparently contradictory findings
is that mitochondrial ROS production in vivo is determined by respiratory
chain redox state, substrate supply, ATP turnover, and membrane
potential, which are all dependent on the ever-changing physiological
conditions in vivo, compared to the stable environment in which isolated
mitochondria are analyzed (Murphy, 2009). Furthermore, mitochondrial
hydrogen peroxide is a redox signal that can alter cell function at levels
too low to cause oxidative damage (Finkel, 2011).
To test whether the accumulation of mtDNA mutations in mutator
mice increased ROS production, we measured hydrogen peroxide in vivo
using the mitochondria-targeted mass spectrometry probe MitoB (Co-
cheme et al., 2011, 2012) (See Appendix S1). MitoB accumulates rapidly
and extensively within mitochondria in vivo following IV injection
(Porteous et al., 2013), where it reacts with hydrogen peroxide to form
the diagnostic exomarker MitoP [although a contribution from perox-
ynitrite cannot be excluded (Cocheme et al., 2011, 2012)]. The mice are
maintained for 6 h after MitoB injection, allowing a MitoP/MitoB ratio to
develop that reflects the average mitochondrial hydrogen peroxide level
in vivo under normal conditions. The tissue MitoP/MitoB ratio is then
determined by liquid chromatography followed by tandem mass
spectrometry (Cocheme et al., 2011, 2012; Chouchani et al., 2013).
There was no difference in MitoP/MitoB ratio between young mutator
mice and age-matched controls (Fig. 1A), even though mtDNA muta-
tions are ~5-fold greater in mutator mice at this age. Therefore, mtDNA
mutation in itself is not sufficient to increase mitochondrial ROS in vivo.
For mature (35–42 weeks) mutator mice, where accelerated aging is
evident, the MitoP/MitoB ratio increased in the heart and kidney
compared to age-matched controls (Fig. 1B). There was also an increase
in MitoP/MitoB ratio for heart, kidney, liver, and skeletal muscle when
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mature and young mutator mice were compared (Fig. 1C). (For the liver,
there was an unexplained bimodal distribution, but the difference
remained statistically significant (P < 0.05) when the upper four points
were excluded.) In contrast, the MitoP/MitoB ratio did not increase for
the same age change in control mice (Fig. 1D, young vs. mature). As
mature mutator mice are close to the end of their lives, we also assessed
the MitoP/MitoB ratio in old control mice (111 weeks) at a similar life
stage to mature mutator mice. The MitoP/MitoB ratio did not increase
with age, comparing mature and old control mice (Fig. 1D). Therefore,
the MitoP/MitoB ratio increases in mutator mice with age to a greater
extent than in control mice, when compared by either chronological age
or life stage.
Mitochondrial tissue content was similar for all the mice (Fig. S1A, B).
The MitoB uptake into tissues was not different between the young
mutator and control mice (Fig. S1C), but was lower for mature mutator
mice compared to mature control mice (Fig. S1D), perhaps reflecting a
decrease in mitochondrial membrane potential in mutator mice with
age. However, as MitoP formation is normalized to MitoB (Cocheme
et al., 2011), this does not affect the MitoP/MitoB ratio, as was
confirmed for the experiments reported here (Fig. S1E). Therefore, these
changes in MitoP/MitoB ratio reflect an increase in mitochondrial
hydrogen peroxide within mutator mice as they age.
The increase in mitochondrial hydrogen peroxide with age in the
mutator mice in vivomay arise from disruption to mitochondrial function
due to mtDNA mutations increasing superoxide production, which is
suppressed in vitro by saturation with substrates and oxygen. As
oxidative damage does not accumulate markedly in mutator mice, the
mtDNA mutations may activate mitochondrial ROS production as part of
subtle redox signaling pathways that contribute to accelerated aging.
Increased apoptosis is associated with elevated mitochondrial ROS,
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Fig. 1 Hydrogen peroxide levels in mutator
and control mice. Mice were injected with
MitoB, and 6 h later, MitoB and MitoP
levels were analyzed. Each point represents
one mouse; data are means  SEM of 7–9
mice. Statistical significance was
determined using Student’s t-test:
*P < 0.05, **P < 0.01. (A) young (6–
20 weeks), (B) mature (35–42 weeks), (C)
young and mature mutator mice, (D)
young, mature or old (111 weeks) control
mice.
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consistent with greater cell death in mutator mice (Kujoth et al., 2005;
Hiona et al., 2010; Ahlqvist et al., 2012). A further possibility is that
mtDNA damage modifies the response of the immune system, perhaps
by triggering the NLRP3 inflammasome, which requires elevated
mitochondrial ROS (Green et al., 2011). To assess this possibility, we
measured the response to immune stimulation with lipopolysaccharide
(LPS) of young and mature mutator and control mice (Fig. 2). The
cytokine profiles of young control and mutator mice were similar
following LPS stimulation (Fig. 2). However, for mature mice, the
increase in some pro-inflammatory cytokines following LPS stimulation
was markedly higher in the mutator compared to control mice (Fig. 2),
notably for IFN-c, TNF-a, IL-1b, and IL-10. Similar enhanced inflamma-
tory activity in response to stimulation is seen with age in control animals
(Tateda et al., 1996; Bruunsgaard et al., 2001). Thus, one possibility is
that the activation of mitochondrial redox signaling in response to
exposure to chronic mtDNA damage generates a pro-inflammatory
environment that contributes to the aging phenotype in mutator mice.
Our findings show that the presence of mtDNA mutations in mutator
mice increases mitochondrial ROS levels with age in vivo, and suggest
that the ROS production contributes to the accelerated aging pheno-
type. Accelerated aging may occur through the activation of pro-
apoptotic and pro-inflammatory redox signaling pathways in response to
mtDNA damage. Whether these mechanisms drive aging in general, are
specific to the mtDNA mutator mouse model, or are merely secondary
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Fig. 2 Measurement of serum cytokines in
young (10–16 weeks) and mature (40–
48 weeks) mutator and age-matched
control mice following injection with LPS or
with saline carrier. Data are means  SEM
of 5–7 mice per treatment group. Statistical
significance was determined between the
LPS-treated young and mature groups for
the mutator and control mice using
Student’s t-test: **P < 0.01, ***P < 0.001.
IL, interleukin; IFN, interferon; TNF, tumor
necrosis factor; KC/GRO, keratinocyte-
derived cytokine.
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consequences of aging are important questions to be addressed in future
work.
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